Loading
Latest filing published 17 Apr 2018 for Canntab Therapeutics Limited.
No signal scores available.
Jeffrey W. Renwick appears in our data through filings on Canntab Therapeutics Limited shares, published by SEDI. Altogether 2 filings, all relating to 11 April 2018.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 17 April 2018 with a transaction in Canntab Therapeutics Limited. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations